Sage Therapeutics, Inc. (SAGE)

NASDAQ: SAGE · Real-Time Price · USD

8.28

-0.38 (-4.39%)

At close: Mar 28, 2025, 4:00 PM

8.38

+0.10 (1.26%)

After-hours: Mar 28, 2025, 5:12 PM EDT

Sage Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	41.24	86.46	7.69	6.31	1,114	Upgrade
Revenue Growth (YoY)	-52.30%	1024.84%	21.84%	-99.43%	16123.06%	Upgrade
Cost of Revenue	235.34	358.39	326.98	283.72	293.28	Upgrade
Gross Profit	-194.1	-271.94	-319.29	-277.41	820.92	Upgrade
Selling, General & Admin	216.42	274.52	227.7	183.5	196.95	Upgrade
Operating Expenses	216.42	274.52	227.7	183.5	196.95	Upgrade
Operating Income	-410.52	-546.46	-546.99	-460.91	623.97	Upgrade
Interest & Investment Income	31.68	38.74	14.19	2.88	9.6	Upgrade
Other Non Operating Income (Expenses)	0.03	-0.38	0.02	0.13	0.25	Upgrade
EBT Excluding Unusual Items	-378.81	-508.1	-532.78	-457.89	633.82	Upgrade
Merger & Restructuring Charges	-21.85	-33.39	-	-	-27.74	Upgrade
Pretax Income	-400.67	-541.49	-532.78	-457.89	606.07	Upgrade
Net Income	-400.67	-541.49	-532.78	-457.89	606.07	Upgrade
Net Income to Common	-400.67	-541.49	-532.78	-457.89	606.07	Upgrade
Shares Outstanding (Basic)	61	60	59	59	52	Upgrade
Shares Outstanding (Diluted)	61	60	59	59	53	Upgrade
Shares Change (YoY)	1.55%	0.89%	1.08%	10.69%	4.27%	Upgrade
EPS (Basic)	-6.59	-9.05	-8.98	-7.80	11.66	Upgrade
EPS (Diluted)	-6.59	-9.05	-8.98	-7.80	11.43	Upgrade
Free Cash Flow	-267.19	-541.14	-460.97	-378.55	663.94	Upgrade
Free Cash Flow Per Share	-4.40	-9.04	-7.77	-6.45	12.53	Upgrade
Gross Margin	-	-	-	-	73.68%	Upgrade
Operating Margin	-995.36%	-632.08%	-7116.69%	-7306.74%	56.00%	Upgrade
Profit Margin	-971.48%	-626.33%	-6931.88%	-7258.91%	54.40%	Upgrade
Free Cash Flow Margin	-647.85%	-625.92%	-5997.57%	-6001.17%	59.59%	Upgrade
EBITDA	-409.49	-545.07	-545.87	-456.73	626.6	Upgrade
EBITDA Margin	-	-	-	-	56.24%	Upgrade
D&A For EBITDA	1.03	1.39	1.12	4.18	2.63	Upgrade
EBIT	-410.52	-546.46	-546.99	-460.91	623.97	Upgrade
EBIT Margin	-	-	-	-	56.00%	Upgrade
Revenue as Reported	41.24	86.46	7.69	6.31	1,114	Upgrade

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q